康希諾生物(06185.HK)重組新冠病毒疫苗獲印度尼西亞清真認證

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

康希諾生物(06185.HK)重組新冠病毒疫苗獲印度尼西亞清真認證

阿思達克 08-17 00:37

康希諾生物(06185.HK)公布，集團開發的重組新型冠狀病毒疫苗(5型腺病毒載體)(商品名︰克威莎)近日收到印度尼西亞烏拉瑪委員會食品、藥品及化妝品評估機構授予清真認證。此次認證標誌克威莎可以進入全球互認的穆斯林市場。

康希諾生物(06185.HK)

Relevant Stocks

康希諾生物(06185.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

康希諾生物(06185.HK)重組新冠病毒疫苗獲印度尼西亞清真認證

Services

About Us

Agreement Statement